Exact Sciences (EXAS) Common Equity: 2009-2024
Historic Common Equity for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $2.4 billion.
- Exact Sciences' Common Equity fell 22.09% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 22.09%. This contributed to the annual value of $2.4 billion for FY2024, which is 23.62% down from last year.
- Per Exact Sciences' latest filing, its Common Equity stood at $2.4 billion for FY2024, which was down 23.62% from $3.1 billion recorded in FY2023.
- In the past 5 years, Exact Sciences' Common Equity registered a high of $3.4 billion during FY2021, and its lowest value of $2.2 billion during FY2020.
- Over the past 3 years, Exact Sciences' median Common Equity value was $3.0 billion (recorded in 2022), while the average stood at $2.9 billion.
- Per our database at Business Quant, Exact Sciences' Common Equity spiked by 51.53% in 2021 and then dropped by 23.62% in 2024.
- Exact Sciences' Common Equity (Yearly) stood at $2.2 billion in 2020, then spiked by 51.53% to $3.4 billion in 2021, then declined by 10.17% to $3.0 billion in 2022, then increased by 3.36% to $3.1 billion in 2023, then decreased by 23.62% to $2.4 billion in 2024.